News/ News/ Oncology/ Top stories FDA fast-tracks Leap’s gastric cancer immunotherapy Phil Taylor BeiGene, gastric cancer, immuno-oncology, Leap Therapeutics, Oncology 0 Comment Leap Therapeutics will get a swift FDA review for its lead drug DKN-01 for a form of gastric Share X FDA fast-tracks Leap’s gastric cancer immunotherapy https://pharmaphorum.com/news/fda-fast-tracks-leaps-gastric-cancer-immunotherapy/
BeiGene, gastric cancer, immuno-oncology, Leap Therapeutics, Oncology
0 Comment
